| Literature DB >> 22536036 |
Justin Townsend1, Avinash Pathengay, Harry W Flynn, Darlene Miller.
Abstract
BACKGROUND: The purpose of this work is to report on the management of endophthalmitis in phakic eyes in which the crystalline lens was preserved.Entities:
Keywords: cataract surgery; intraocular; intravitreal; phakic eyes
Year: 2012 PMID: 22536036 PMCID: PMC3334216 DOI: 10.2147/OPTH.S26683
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Demographic information, etiology of infection, treatment and causative organism in a phakic endophthalmitis series
| Patient | Gender, age (years), eye | Category | Predisposing factor | Anterior chamber reaction | Vitritis | Treatment/intraocular therapy | Culture result | ||
|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 58 | L | Endogenous | Foot ulcer | 3+ | 2+ | PPV, ampho, vanc, ceftaz | |
| 2 | F | 64 | L | Endogenous | ICU patient | 3+ | 3+ | PPV, ampho, dex, oral fluconazole | |
| 3 | F | 50 | R | Endogenous | Osteomyelitis, indwelling catheter | 3+ | 3+, infiltrates | Ampho, oral fluconazole | |
| 4 | M | 56 | R | Endogenous | Colorectal surgery | 3+ | 3+ | Ampho, intravenous fluconazole, PPV (after 2 months) | |
| L | Endogenous | Colorectal surgery | 2+ | 2+, infiltrates | PPV, ampho, intravenous fluconazole | ||||
| 5 | M | 43 | R | Endogenous | IVDA | 3+ | 3+ | PPV, ampho, vanc, ceftaz, oral fluconazole | |
| 6 | M | 32 | R | Trauma | Dust blown in eye | 3+ | 1+ | PPV, vori | |
| 7 | F | 72 | L | Postoperative | Status post glaucoma filtering surgery | 3+ | Trace | Vanc, ceftaz, dex | Moraxella species |
| 8 | M | 50 | R | Postoperative | Status post glaucoma filtering surgery | 3+ | 1+ | Gent, intravitreal cefazolin | |
| 9 | F | 62 | L | Postoperative | Status post glaucoma filtering surgery | 3+ | PPV, vanc, ceftaz, dex | ||
| 10 | F | 76 | R | Postoperative | Status post glaucoma filtering surgery | 4+ | Gent, vanc, ceftaz, dex | Coagulase-negative | |
| 11 | M | 71 | R | Postoperative | Status post PPV for NCVH | Large hypopyon | Vit hemorrhage | Vanc, ceftaz, dex | |
Note: Anterior chamber reaction, vitritis and chorioretinitis are as noted by the treating physician.
Abbreviations: ICU, intensive care unit; PPV, pars plana vitrectomy; vanc, intravitreal vancomycin; gent, intravitreal gentamicin; ceftaz, intravitreal ceftazidime; ampho, intravitreal amphotericin B; vori, intravitreal voriconazole; dex, intravitreal dexamethasone; NCVH, nonclearing vitreous hemorrhage.
Pretreatment and post-treatment lens status, visual acuity results, and duration of follow-up in phakic endophthalmitis series
| Patient | Pretreatment lens status | Final lens status (before CE) | Presenting visual acuity | Final visual acuity | Follow-up (months) | Comment |
|---|---|---|---|---|---|---|
| 1 | Clear | 1+NS | 20/30− | 20/25 | 12 | Chronic peripheral RD |
| 2 | Clear | 3+PSC | 20/200 | NLP | 6 | Recurrent RD |
| 3 | Clear | 1+NS | 20/80 | 20/20 | 12 | |
| 4 | Clear | 4+NS | 20/100 | 20/100 | 23 | CE at 9 months macular scar |
| Clear | 2+NS | 20/50 | 20/30 | 23 | ||
| 5 | Trace NS | 1+NS | HM | 20/80 | 51 | |
| 6 | Clear | Trace NS | 20/30− | 20/20 | 7 | |
| 7 | 2+NS | 3+NS | 20/400 | 20/25 | 53 | CE after 22 months |
| 8 | 1+PSC | 2+NS, 2+PSC | 20/200 | 20/30 | 96 | |
| 9 | 1+NS | 3+NS, 3+PSC | LP | 20/60 | 83 | CE after 10 months |
| 10 | 1+NS | 2+NS | 20/400 | 20/40–2 | 73 | CE after 12 months |
| 11 | 1+NS | 3+NS, 3+PSC | HM | 6/200 | 31 | CE after 27 months; macular scar, band keratopathy |
Note: Lens status is as noted by the treating physician.
Abbreviations: CE, cataract extraction; NS, nuclear sclerosis; PSC, posterior subcapsular cataract; HM, hand motion; LP, light perception; NLP, no light perception; RD, retinal detachment.
Figure 1Patient 3, a 50-year-old female with a history of osteomyelitis and chronic intravenous antibacterial treatment. (A) Fundus at presentation. Visual acuity 20/80. Systemic candidemia and endogenous Candida albicans endophthalmitis OD. (B) Fundus 11 months after presentation. Patient treated with intravitreal amphotericin B and systemic fluconazole. Visual acuity 20/20.
Figure 2Patient 7, a 72-year-old female with history of glaucoma filtering surgery OS 8 months prior to presentation. (A) Slit lamp at presentation. Visual acuity 20/400. Culture positive for Moraxella species. (B) Slit lamp 2 months after presentation. Patient treated with intravitreal vancomycin, ceftazidime, and dexamethasone. Visual acuity 20/25. (C) Slip lamp 22 months after presentation, 4 months after uncomplicated phaco/intraocular lens implantation OS. Visual acuity 20/25.
Clinical characteristics and outcome comparison between case series
| Huang et al | Current study | |
|---|---|---|
| Study years | 1980–1989 | 1995–2009 |
| Number of cases | 12 | 12 |
| Etiology (number of cases) | ||
| Endogenous | 7 | 6 |
| Postoperative | 4 | 5 |
| Traumatic | 1 | 1 |
| Treatment (number of cases) | ||
| PPV + intravitreal abx | 7 | 7 |
| Intravitreal abx | 5 | 5 |
| VA outcomes (number of cases) | ||
| ≥20/80 | 6 | 9 |
| 20/100–20/400 | 1 | 1 |
| <20/400 | 5 | 2 |
| CE + IOL during follow-up | 2 | 5 |
Abbreviations: IOL, intraocular lens; CE, cataract extraction; PPV, pars plana vitrectomy; VA, visual acuity.